CompletedNot Applicable

Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas

United States, Uganda672 participantsStarted 2021-10-05

Plain-language summary

The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the a portable near-infrared-based device (portable NIR-based device), the InfraScanner 2000™, to detect intracranial hematomas (epidural hematomas (EDH) and/or subdural hematomas (SDH)) in patients hospitalized at Mbarara Regional Referral Hospital (MRRH) who have sustained or who are suspected to have sustained head trauma.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any patient who presents to MRRH with suspected head trauma, who is able to or who has a legally authorized representative who is able consent in English, Swahili, or Luganda will be considered for this study. Exclusion Criteria: * None

What they're measuring

Number of Participants With Detection of Hematoma Stratified by CT Positive and CT Negative Status

Timeframe: Within 30 minutes following CT scan

Trial details

NCT IDNCT04505293

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-29

Results submitted2023-06-06

View on ClinicalTrials.gov More Head Trauma trials